Skip navigation

Strategies to Scale the Business and Best Practices for Accounting and Reporting

September 21-23, 2020
  • Boston, MA

CBI’s 4th Annual Finance & Accounting for Bioscience Companies convenes professionals from life sciences organizations to discuss strategies finance R&D, scale the business, optimize financial reporting processes, mitigate risk and elevate talent/teams. This meeting convenes over 300 senior-level executives and hones-in on the unique challenges faced by small and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and commercialize products. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

Highlights for 2020 Include:

  • Exploration of new financing models and
    investment trends
  • Update on changing technical accounting standards
    and regulations
  • Roadmap for new product launch and commercialization
    strategies for finance and accounting teams
  • Insight on financial systems, software and
    processes to gain efficiencies and effectiveness
  • Strategies for R&D collaborations and licensing deals
  • Considerations for corporate tax and valuation
  • Case studies illustrating high growth and
    scalability of emerging biotech companies
  • Industry perspectives on third party risk,
    oversight of outsourced service providers and
    CRO partnership optimization
  • Best practices for recruiting and retaining
    top talent and technical expertise
  • Networking opportunities with elite speakers and
    industry thought leaders

A Valuable Learning and Networking Experience, Highly Rated By Peers!

Timely topics, excellent presenters, lively engaged audience and excellent networking opportunity!

CFO, Contrafect

The Finance and Accounting for Bioscience Companies conference was extremely well run with valuable content and programming.

Partner, White & Williams LLP

This was great! It was helpful to focus on topics that impact smaller biotechs. In particular, the interactive panels provided great perspectives.

Anonymous

This was a great conference. I enjoyed the technical learning sessions, then followed up with the industry panel discussions for participants to understand how these issues are incorporated into the real world.

Controller, KSQ Therapeutics, Inc.

The conference provided a great discussion and better understanding on relevant issues impacting us, while allowing participants to gain insights and best practices from the speakers.

Anonymous

The conference addressed many hot topics that are faced by fast growing biotechs!

Anonymous

Thank you for the timely discussions on the changing accounting and SEC rules. Excellent opportunity to learn from peers.

Anonymous

Great topics and incredible attendees.

Anonymous

4th Annual Finance & Accounting for Bioscience Companies

Strategies to Scale the Business and Best Practices for Accounting and Reporting

CBI’s 4th Annual Finance & Accounting for Bioscience Companies convenes professionals from life sciences organizations to discuss strategies finance R&D, scale the business, optimize financial reporting processes, mitigate risk and elevate talent/teams. This meeting convenes over 300 senior-level executives and hones-in on the unique challenges faced by small and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and commercialize products. Gain strategies to ensure regulatory compliance, train new team members, implement systems and effectively communicate financial performance.

Highlights for 2020 Include:

  • Exploration of new financing models and
    investment trends
  • Update on changing technical accounting standards
    and regulations
  • Roadmap for new product launch and commercialization
    strategies for finance and accounting teams
  • Insight on financial systems, software and
    processes to gain efficiencies and effectiveness
  • Strategies for R&D collaborations and licensing deals
  • Considerations for corporate tax and valuation
  • Case studies illustrating high growth and
    scalability of emerging biotech companies
  • Industry perspectives on third party risk,
    oversight of outsourced service providers and
    CRO partnership optimization
  • Best practices for recruiting and retaining
    top talent and technical expertise
  • Networking opportunities with elite speakers and
    industry thought leaders

A Valuable Learning and Networking Experience, Highly Rated By Peers!

Timely topics, excellent presenters, lively engaged audience and excellent networking opportunity!

CFO, Contrafect

The Finance and Accounting for Bioscience Companies conference was extremely well run with valuable content and programming.

Partner, White & Williams LLP

This was great! It was helpful to focus on topics that impact smaller biotechs. In particular, the interactive panels provided great perspectives.

Anonymous

This was a great conference. I enjoyed the technical learning sessions, then followed up with the industry panel discussions for participants to understand how these issues are incorporated into the real world.

Controller, KSQ Therapeutics, Inc.

The conference provided a great discussion and better understanding on relevant issues impacting us, while allowing participants to gain insights and best practices from the speakers.

Anonymous

The conference addressed many hot topics that are faced by fast growing biotechs!

Anonymous

Thank you for the timely discussions on the changing accounting and SEC rules. Excellent opportunity to learn from peers.

Anonymous

Great topics and incredible attendees.

Anonymous